Drug Alert – September 2019
Central Drugs Standard Control Organisation released Drug Alert for the month of September 2019
List of Drugs, Medical Devices and Cosmetics declared as Not of Standard Quality / Spurious / Adulterated / Misbranded, for the Month of September 2019
- Total number of samples tested 1134
- Total number of samples declared as of Standard Quality 1113
- Total number of samples declared as Not of Standard Quality 21
- Total number of samples declared as Spurious Nil
- Total number of samples declared as Misbranded Nil
Drug Alert – September 2019
- Ciprofloxacin Tablets IP 500 Mg – Dissolution
- Pantoprazole Sodium Tablets IP 40 mg – Assay
- Norfloxacin Tablet I.P. 400 mg. – Dissolution
- Chloramphenicol Capsules I.P. 250 mg. (Starphenicol 250) – Dissolution
- Thyrocure-50 (Thyroxine Tablets I.P. 50 mcg) – Assay
- Dispersible Paracetamol Tablets B.P. 250 mg – Fineness of Dispersion
- Primaquine Tablets IP 2.5mg – Uniformity of Content, Dissolution and Assay
- Primaquine Tablets I.P. – Uniformity of Content and Assay
- Ranitidine Injection I.P. – Particulate Matter
- Amiject 500 (Amikacin Sulphate Injection I.P.) – Description & Particulate Matter
- PQ-7.5 (Primaquine Phosphate Tablets I.P.) – Uniformity of Content, Dissolution & Assay
- Cetfast (Cetirizine Hydrochloride Tablets I.P.) – Assay
- Okacet-L (Levocetirizine Tablets I.P. 5 mg) – Related Substances
- Zylocef-S 375 (Ceftriaxone & Sulbactam for Injection) – Clarity of Solution & Particulate Matter
- Atorvastatin Tablets IP 20mg – Assay
- Calcium Carbonate Tablets I.P. – Uniformity of Weight
- Cetirizine Hydrochloride Tablets IP 10mg – Related Substances
- Mycophenolate Sodium Tablets USP 720 mg (Mycophaz-720 Tablets) – Identification of Mycophenola te Sodium
- Ofloxacin Tablets 400 mg (Ofloz-400 Tablets) – Uniformity of weight and Assay
- Sucralfate with Oxetacaine Oral Suspension (Sucrazed-O Suspension) – Assay of Sucralfate
- Sucralfate with Oxetacaine Oral Suspension (Sucrazed-O Suspension) – Assay of Sucralfate